Search Result For "targeted cancer therapy"
Brand No available data!
Generic No available data
Generic Name : Trastuzumab deruxtecan
Indication : Monotherapy for the treatment of adult patients w/ unresectable or metastatic HER2 +ve breast cancer who have received ≥1 prior anti-HER2-based regimens.
Manufacturer : Daiichi Sankyo
Distributor : Zuellig Pharma
Marketer : Daiichi Sankyo
Local Product Insert : Click to view
Generic Name : Erlotinib
Indication : 1st-line treatment in locally advanced or metastatic NSCLC w/ epidermal growth factor receptor (EGFR) activating mutations. Locally advanced or metastatic NSCLC w/ EGFR activating mutations & stab...
Manufacturer : Natco Pharma
Distributor : Atlanta Medicare
Local Product Insert : Click to view
Generic Name : Erlotinib
Indication : Locally advanced or metastatic NSCLC after failure of at least 1 prior chemotherapy regimen. In combination w/ gemcitabine for the 1st-line treatment of patients w/ locally advanced, unresectable or m...
Manufacturer : Sandoz
Distributor : Zuellig Pharma
Local Product Insert : Click to view
Generic Name : Pralsetinib
Indication : Adults w/ advanced or metastatic NSCLC rearranged during transfection (RET) fusion +ve. Adult & ped patients ≥12 yr w/ advanced or metastatic RET-mutant medullary thyroid cancer (MTC) requiring...
Manufacturer : Roche
Distributor : DKSH
Marketer : Roche
Generic Name : Obinutuzumab
Indication : Chronic lymphocytic leukemia (CLL) in combination w/ chlorambucil. Follicular lymphoma (FL) in combination w/ chemotherapy followed by Gazyva maintenance for previously untreated patients & w/ ben...
Manufacturer : Roche
Distributor : DKSH
Generic Name : Gefitinib
Indication : Monotherapy for locally advanced or metastatic NSCLC w/ activating mutations of epidermal growth factor receptor tyrosine kinase in adults.
Manufacturer : Pacific Healthcare
Distributor : Pacific Healthcare
Local Product Insert : Click to view
Generic Name : Gefitinib
Indication : 1st-line treatment of patients w/ locally advanced or metastatic NSCLC who have activating mutations of EGFR-TK. Locally advanced or metastatic NSCLC in patients who have previously received chemother...
Manufacturer : Sandoz
Distributor : Zuellig Pharma
Marketer : Novartis
Related Diseases

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in .
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in .
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in